Skip to main content
Log in

Nanonization-Based Solubility Enhancement by Loaded Porous Starch Foam: Nifedipine Tablet Formulation

  • Original Article
  • Published:
Journal of Pharmaceutical Innovation Aims and scope Submit manuscript

Abstract

Background

Nifedipine (NIF) is a 1,4-dihydropyridine, calcium channel blocker, widely used in the treatment of cardiovascular diseases. NIF is poorly soluble in water at room temperature. Biodegradable porous starch foam (BPSF) has great potential as a solid dispersion carrier and can improve the solubility of poorly water-soluble drugs like NIF.

Objective

To formulate and evaluate tablet formulation of nifedipine-loaded biodegradable porous starch foam to improve the solubility of the drug.

Methods

The physical properties and the dissolution profile of NIF/BPSF mixtures and tablets were investigated. The BPSF was prepared by using a solvent exchange method, and NIF was loaded using an immersion/solvent evaporation method. The samples were characterized using differential scanning calorimetry (DSC), Fourier transform infrared spectroscopy (FTIR), powder X-ray diffraction (PXRD), and optical microscopy.

Results

The in vitro dissolution studies demonstrated the immediate release of NIF from the BPSF formulated tablets. The formulation containing a ratio of NIF:BPSF (1:10) gave around 70% drug release in 30 min as compared to the control NIF tablets that showed 11% drug release.

Conclusion

These results showed an increase in the drug release of NIF from BPSF as a carrier thereby supporting the mechanism of drug adsorption.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Savjani KT. Drug solubility: importance and enhancement techniques. ISRN pharmaceutics. 2012.

  2. Dave RH. Overview of pharmaceutical excipients used in tablets and capsules. Drug Topics 2008:1–13.

  3. Rodriguez-Aller MG. Strategies for formulating and delivering poorly water-soluble drugs. Journal of Drug Delivery Science and Technology. 2015;30:342–51.

    Article  CAS  Google Scholar 

  4. Kawabata YW. Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications. Int J Pharm. 2011;420(1):1–10.

    Article  CAS  PubMed  Google Scholar 

  5. Benet LZ. The role of BCS (biopharmaceutics classification system) and BDDCS (biopharmaceutics drug disposition classification system) in drug development. J Pharm Sci. 2013;102(1):34–42.

    Article  CAS  PubMed  Google Scholar 

  6. Carvalho AJ. 7 starch: major sources, properties and applications as thermoplastic materials. Handbook of biopolymers and biodegradable plastics: properties, processing and applications 2012:129- 152.

  7. Robyt JF. Starch: structure, properties, chemistry, and enzymology. In J. F. Robyt, Glycoscience: chemistry and chemical biology. 2008:1437–1472. Springer, Berlin, Heidelberg.

  8. Rowe RC. Handbook of pharmaceutical excipients 6th edition. London: London: Pharmaceutical Press. 2009.

  9. Liu LS. Porous starch and its applications. 2018. 0.1007/978–981–13–1077–5_4.

  10. Wu CW. Development of biodegradable porous starch foam for improving oral delivery of poorly water-soluble drugs. Int J Pharm. 2011;403(1–2):162–9.

    Article  CAS  PubMed  Google Scholar 

  11. PubChem. National Center for Biotechnology Information. PubChem Database. Nifedipine, CID=4485. 2019. Retrieved from PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/Nifedipine.

  12. Lin CW. Effect of particle size on the available surface of nifedipine from nifedipine-polyethylene glycol 6000 solid dispersions. Int J Pharm. 1996;127:261–72.

    Article  CAS  Google Scholar 

  13. Portero AR-L-J. Effect of chitosan and chitosan glutamate enhancing the dissolution properties of poorly water soluble drug nifedipine. Int J Pharm. 1998;175:75–84.

    Article  CAS  Google Scholar 

  14. Cilurzo FM. Characterization of nifedipine solid dispersions. Interanational Journal of Pharmaceutics. 2002;242:313–7.

    Article  CAS  Google Scholar 

  15. Sugimoto IK. Stability of nifedipine-polyvinylpyrrolidone coprecipitate. Chem Pharm Bulletin. 1981;29:1715–23.

    Article  CAS  Google Scholar 

  16. Zajc NO. Physical properties and dissolution behaviour of nifedipine/mannitol solid dispersions prepared by hot melt method. Int J Pharm. 2005;291(1–2):51–8.

    Article  CAS  PubMed  Google Scholar 

  17. Hecq JD. Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine. Int J Pharm. 2005;299(1–2):167–77.

    Article  CAS  PubMed  Google Scholar 

  18. Kanagathara NS. Fourier transform infrared spectroscopic investigation on nifidipine. International Journal of Pharmacy and Biological Sciences. 2011;1:52–6.

    CAS  Google Scholar 

  19. Yiotis AG. A 2-D pore-network model of the drying of single-component liquids in porous media. Adv Water Resour. 2001;24(3–4):439–60.

    Article  CAS  Google Scholar 

  20. Ali MT. Porous starch: a novel carrier for solubility enhancement of carbamazepine. AAPS PharmSciTech. 2013;14(3):919–26.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors would like to thank Mr. Sujay Gurav for providing help during the studies.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Antoine Al-Achi.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chaudhari, P.M., Johnson, P., Mhetre, R.L. et al. Nanonization-Based Solubility Enhancement by Loaded Porous Starch Foam: Nifedipine Tablet Formulation. J Pharm Innov 18, 60–67 (2023). https://doi.org/10.1007/s12247-022-09622-4

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12247-022-09622-4

Keywords

Navigation